MEVOPUR COLORANTS • Standard colors in PP and PE to shorten time-to-market • Custom colors matched to Pantone, RAL or other color reference • White colorants for pharmaceutical packaging for LDPE, HDPE and PP with opacity to reach USP chapter MEVOPUR FUNCTIONAL ADDITIVES • Antistatic formulation with good flow/impact for injection molding • Amide- and amine-free antistatic for film in contact with API (Active Pharmaceutical Ingredients) • UV blocking for transparent PP and PE packaging to meet USP chapter • Non-migrating friction reduction/processing aid for PE and PP • Laser marking/welding additive for fast, reliable marking/assembly • MVTR (Moisture Vapor Transmission Rate) reduction for HDPE to improve shelf-life • Thermal protection of the polymer during processing • Gamma/e-beam sterilization protection for PP (up to 50kGy) with color compensation for reduced yellowing REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request Bormed™ is a registered trademark of Borealis Healthcare use limitations apply—see below.

Cesa Stat Antistatic Additives for automotive can support customers with electrostatic decay time testing according to Standard DIN EN 61340-2-1 to speed up the development.

KEY CHARACTERISTICS • Available for polyethylene, polypropylene, ABS, polycarbonate and styrenics • Bio-content of resin carrier varies from 70% to 100% depending on polymer—calculated to ASTM D6866 standard • Manufactured at four ISO 13485 certified sites, providing global consistency and security of supply • Documented change control beyond CAS number, reducing risk of change • Drop-in solutions that can be processed like fossil-based grades on common injection molding and extrusion machines • Can be provided as ready-to-use pre-colored or additive formulation REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP and (incl. class VI) - European Pharmacopeia, monograph 3.1.3/ 3.1.5 (polyolefin packaging materials) - USP (polyethylene) - Elemental impurities as per ICH Q3D • Registered Drug Master File (Type III) and/or Device Master File • Food contact according to US FDA and APPLICATION BULLETIN Sustainability Spotlight Bio-polymers Healthcare use limitations apply—see below.

REGULATORY SUPPORT • Drug delivery devices • Pharmaceutical packaging • Medical equipment KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number level, reducing the risk of change • Allows crystallization in semi-crystalline polymers to begin faster and complete earlier REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request Healthcare use limitations apply—see below.

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified sites, providing global consistency and increased security of supply • Documented change control beyond CAS number level, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Different tones of amber available on request —more or less red or yellow and/or lighter or darker • Also available in liquid form REGULATORY SUPPORT • Pre-tested raw materials: - ISO 10993-1 and USP parts (Class VI) - European Pharmacopeia, monograph 3.1.15, USP and elemental analysis as per ICH Q3D - USP criteria appearance of solution, color • Registered Drug Master File (Type III) by the FDA • Food contact compliance established with FDA/EU* • YBB00102002-2015 (oral liquid pharmaceutical PET bottles) compliance support APPLICATION BULLETIN * FDA/EU compliance information available upon request Healthcare use limitations apply—see below.

For and on behalf of BSI: Carlos Pitanga, Chief Operating Officer Assurance – Americas Certification Date: 2018-07-11 Latest Issue: 2018-07-11 Expiry Date: 2021-07-10 BSI Certificate Number: 85585 IATF Number: 0315491 Page: 1 of 2 This certificate remains the property of BSI and shall be returned immediately upon request.

They are available for processes including extrusion, injection molding, blow molding, rotational molding and thermoforming. 1. https://www2.deloitte.com/us/en/pages/technology-media-and- telecommunications/articles/global-mobile-consumer-survey-us-edition.html 2. https://cals.arizona.edu/news/why-your-cellphone-has-more-germs-toilet www.avient.com Copyright © 2020, Avient Corporation.

Further, according to international standard IEC 60670-1, the materials used in the wall boxes have to pass a Glow Wire Flammability Index (GWFI) 850°C testing (IEC 60695-2-12) at the application thickness, and 960°C at 2mm.

PRODUCT RANGE HIGHLIGHTS Amosorb™ 4020E • Non-nylon based oxygen scavenging technology for PET • Helps to prolong the shelf life of many products in major markets Amosorb™ 100 • Non-nylon based oxygen scavenging technology for PET • Developed to meet the needs of the North American market • Featuring a special additivation package to allow for pre-consumer regrind Amosorb™ 4020G • Lower haze levels and lower impact on PET recycle stream • Non-nylon based active oxygen scavenger • PET and rPET compatible • Can be used with mono-layer and multi-layer applications Amosorb™ 4020R • Consistent performance with all levels of rPET (25%, 50% and 100%) • Improved haze and color when in combination with rPET • Flexibility on choice of rPET grade • Non-nylon based product Amosorb™ SolO2 -1 (non-carbonated/ carbonated) and SolO2 -2 (carbonated) • Nylon based oxygen scavenging technologies for PET • Active barrier effect to prevent O2 ingress • Passive barrier effect to prevent gas ingress and digress from the packaging (i.e.

This additive technology can be implemented during PET processing without impact on production efficiency. 0 10 20 30 40 50 60 70 80 0.050 0.1 0.15 0.2 % A A Re du ct io n % Use Rate Anthranilamide 0 10 20 30 40 50 60 70 80 90 .04 .06 .08.020 0.1 0.16 0.180.140.12 0.2 % A A Re du ct io n % Triple A-1+ 1.844.4AVIENT www.avient.com Copyright © 2022, Avient Corporation.